The Immunex Research & Development Center will contain 1.1million sf of usable space, into which it will consolidate itsheadquarters, R&D and other Seattle operations. To facilitateaccess to the biopharmaceutical company's new complex, the cityrecently approved plans to build a new overpass spanning ElliottAvenue and adjacent railroad tracks. The company expects to breakground on the project sometime in the first quarter of 2001.

Triad is targeting Interbay for possible development as itreportedly views the area as a natural continuation of thecommercial redevelopment of Seattle's waterfront. Though theSeattle developer's acquisitions there currently measure less thanone acre, sources tell GlobeSt that Triad has expressed interest insome of the six surrounding acres now owned by Tsubota Investments.No Triad spokesman was immediately available for comment.

Gordon Fouts of Colliers International represented owner,Cloverdale Investments of Vancouver BC, in the recently inked28,500-sf lease by Staples Inc. in the 52,000-sf Funplex buildingon Elliott. According to Fouts, the $9 billion retailer of officesupplies, furniture and technology is planning to spend about $1million renovating the space for a new retail store there.